Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) agreed to acquire 51% stake in Hongxi Medical Technology (Tianjin) Co., Ltd. from Li Zhanbing, Tian Bin, Zhang Hengrui and Xiong Rongliang for CNY 0 on January 17, 2024. As of October 31, 2023, Hongxi Medical Technology (Tianjin) Co., Ltd. generated total assets of CNY 0.28 million and net assets of
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.46 CNY | -2.55% | -10.98% | -38.28% |
1st Jan change | Capi. | |
---|---|---|
-38.28% | 184M | |
+42.61% | 750B | |
+34.11% | 606B | |
-6.27% | 356B | |
+18.79% | 326B | |
+6.26% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.40% | 167B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Tibet Duo Rui Pharmaceutical Co.,Ltd. agreed to acquire 51% stake in Hongxi Medical Technology Co., Ltd. for CNY 0.